- Home
- LH vs PODD Comparison
LH vs PODD Comparison
Compare LH & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LH
- PODD
- Stock Information
- Founded
- LH 1971
- PODD 2000
- Country
- LH United States
- PODD United States
- Employees
- LH N/A
- PODD N/A
- Industry
- LH Medical Specialities
- PODD Medical/Dental Instruments
- Sector
- LH Health Care
- PODD Health Care
- Exchange
- LH Nasdaq
- PODD Nasdaq
- Market Cap
- LH 23.1B
- PODD 23.8B
- IPO Year
- LH N/A
- PODD 2007
- Fundamental
- Price
- LH $279.89
- PODD $337.94
- Analyst Decision
- LH Strong Buy
- PODD Strong Buy
- Analyst Count
- LH 13
- PODD 18
- Target Price
- LH $290.00
- PODD $334.50
- AVG Volume (30 Days)
- LH 440.2K
- PODD 551.8K
- Earning Date
- LH 10-23-2025
- PODD 11-06-2025
- Dividend Yield
- LH 1.03%
- PODD N/A
- EPS Growth
- LH 72.08
- PODD N/A
- EPS
- LH 9.07
- PODD 3.32
- Revenue
- LH $13,483,800,000.00
- PODD $2,359,500,000.00
- Revenue This Year
- LH $10.89
- PODD $29.18
- Revenue Next Year
- LH $4.83
- PODD $18.09
- P/E Ratio
- LH $30.85
- PODD $102.04
- Revenue Growth
- LH 7.98
- PODD 26.00
- 52 Week Low
- LH $209.38
- PODD $220.10
- 52 Week High
- LH $283.47
- PODD $353.50
- Technical
- Relative Strength Index (RSI)
- LH 59.85
- PODD 58.39
- Support Level
- LH $273.28
- PODD $330.00
- Resistance Level
- LH $279.00
- PODD $353.50
- Average True Range (ATR)
- LH 4.42
- PODD 7.24
- MACD
- LH -0.54
- PODD -0.83
- Stochastic Oscillator
- LH 84.64
- PODD 40.90
About LH Laboratory Corporation of America Holdings
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.